IM Cannabis Corp.
IMCCNASDAQHealthcare● Active
$0.30
+$0.02(+8.11%)
Market Cap$913293
P/E Ratio—
52W High$3.75
52W Low$0.219
IM Cannabis Corp. (IMCC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IMCC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.28
Revenue
$0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
IMCC reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 17, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | May 13, 2026 | — | -$0.28 | — | $0.00B | — | — |
| ▼ Q1 FY2026 | Mar 30, 2026 | $0.09 | -$0.86 | -1100.5% | $0.01B | $0.02B | -47.7% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -$0.02 | -$0.54 | -2234.6% | $0.01B | $0.01B | -30.4% |
| ▲ Q3 FY2025 | Aug 12, 2025 | -$0.14 | -$0.07 | +48.8% | $0.01B | $0.01B | -27.6% |
| ▲ Q2 FY2025 | May 15, 2025 | -$0.25 | $0.06 | +123.6% | $0.01B | $0.01B | -23.6% |
| ▲ Q1 FY2025 | Mar 31, 2025 | -$0.39 | -$0.23 | +41.0% | $0.01B | $0.01B | -8.2% |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$0.70 | -$0.30 | +57.1% | $0.01B | $0.01B | -29.4% |
Q3 FY2026
Aug 17, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026
EPS Actual
-$0.28
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2026
Mar 30, 2026Miss
EPS Actual
-$0.86
EPS Est.
$0.09
EPS Surpr.
-1100.5%
Revenue
$0.01B
Q4 FY2025
Nov 13, 2025Miss
EPS Actual
-$0.54
EPS Est.
-$0.02
EPS Surpr.
-2234.6%
Revenue
$0.01B
Q3 FY2025
Aug 12, 2025Beat
EPS Actual
-$0.07
EPS Est.
-$0.14
EPS Surpr.
+48.8%
Revenue
$0.01B
Q2 FY2025
May 15, 2025Beat
EPS Actual
$0.06
EPS Est.
-$0.25
EPS Surpr.
+123.6%
Revenue
$0.01B
Q1 FY2025
Mar 31, 2025Beat
EPS Actual
-$0.23
EPS Est.
-$0.39
EPS Surpr.
+41.0%
Revenue
$0.01B
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$0.30
EPS Est.
-$0.70
EPS Surpr.
+57.1%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.12 | $0.12 | $0.12 | 1 |
| Q3 FY2025 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q2 FY2025 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Q1 FY2025 | $-0.36 | $-0.36 | $-0.36 | 1 |
| Q4 FY2024 | $-0.54 | $-0.54 | $-0.54 | 1 |
| Q3 FY2024 | $-0.95 | $-0.95 | $-0.95 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 13, 2026 | — | $0.25 | $0.25 | -0.12% |
| ▼ Q1 FY2026 | Mar 30, 2026 | -1100.5% | $0.51 | $0.41 | -20.37% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -2234.6% | $1.44 | $1.31 | -9.03% |
| ▲ Q3 FY2025 | Aug 12, 2025 | +48.8% | $2.93 | $2.60 | -11.26% |
| ▲ Q2 FY2025 | May 15, 2025 | +123.6% | $1.51 | $1.63 | +7.95% |
| ▲ Q1 FY2025 | Mar 31, 2025 | +41.0% | $1.84 | $1.51 | -17.93% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +57.1% | $2.80 | $2.83 | +1.07% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +79.8% | $2.76 | $2.99 | +8.33% |
Q2 FY2026-0.12%
Report Date
May 13, 2026
EPS Beat/Miss
—
Price Before
$0.25
Price After
$0.25
Q1 FY2026-20.37%
Report Date
Mar 30, 2026
EPS Beat/Miss
-1100.5%
Price Before
$0.51
Price After
$0.41
Q4 FY2025-9.03%
Report Date
Nov 13, 2025
EPS Beat/Miss
-2234.6%
Price Before
$1.44
Price After
$1.31
Q3 FY2025-11.26%
Report Date
Aug 12, 2025
EPS Beat/Miss
+48.8%
Price Before
$2.93
Price After
$2.60
Q2 FY2025+7.95%
Report Date
May 15, 2025
EPS Beat/Miss
+123.6%
Price Before
$1.51
Price After
$1.63
Q1 FY2025-17.93%
Report Date
Mar 31, 2025
EPS Beat/Miss
+41.0%
Price Before
$1.84
Price After
$1.51
Q4 FY2024+1.07%
Report Date
Nov 14, 2024
EPS Beat/Miss
+57.1%
Price Before
$2.80
Price After
$2.83
Q3 FY2024+8.33%
Report Date
Aug 14, 2024
EPS Beat/Miss
+79.8%
Price Before
$2.76
Price After
$2.99
Avg Beat Reaction-2.37%
Avg Miss Reaction-14.70%
Beat Rate5 / 8 quarters
Largest Move-20.37% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IMCC ends December
IM Cannabis Corp. (IMCC) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.28 (in line with the analyst consensus of —). The next IMCC earnings date is expected around September 1, 2026.
Each quarter, investors track IMCC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IMCC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IMCC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IMCC earnings · 4 questionsIM Cannabis Corp.'s next earnings report is expected around September 1, 2026. IMCC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IMCC historically reports after market close (AMC).
IMCC earnings datewhen is IMCC earningsIMCC next earnings datewhen does IMCC report earningsIMCC earnings calendar
▸ Source: FMP · IM Cannabis Corp. SEC filings · US GAAP · IM Cannabis Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026